Home > News > Alltracel's Nanopeutics Subsidiary Agrees Exclusive Nanotechnology Development...
November 13th, 2006
Alltracel's Nanopeutics Subsidiary Agrees Exclusive Nanotechnology Development...
Abstract:
Alltracel Pharmaceuticals Plc., ("Alltracel", or "the Company"),(LSE: AP) the Medical Technology Company focused on the Woundcare, Oralcare and Cardiovascular Health markets today announces that
Nanopeutics(TM) s.r.o., ("Nanopeutics"), the specialist subsidiary dedicated to the commercialisation of Nanospider(TM) technology for the global woundcare market, has signed an exclusive partnership agreement with a world leader in the professional woundcare market.
Source:
PR Newswire
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Military
Single atoms show their true color July 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Food/Agriculture/Supplements
Silver nanoparticles: guaranteeing antimicrobial safe-tea November 17th, 2023
Night-time radiative warming using the atmosphere November 17th, 2023
DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||